Article
Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.
Nature clinical practice. Endocrinology & metabolism - 1 Jul 2006
Savage Martin O, Attie Kenneth M, David Alessia, Metherell Louise A, Clark Adrian J L, Camacho-Hübner Cecilia
Abstract excerpt
Advances in the diagnosis and treatment of growth hormone insensitivity disorders have occurred in the past 15 years. We discuss the current status of endocrine and molecular evaluation, focusing on the pediatric age range. All the identified mutations of the growth hormone receptor are included. Treatment with recombinant human insulin-like growth factor (rhIGF) 1 in classical cases is summarized and new targets...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
